Halozyme Therapeutics shares owned by Frontier Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Frontier Capital Management
from 13F filings
Historical chart of Frontier Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Frontier Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Frontier Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $27M | 343k | 78.27 |
| 2024-09-30 | $73M | 1.3M | 57.24 |
| 2024-06-30 | $44M | 846k | 52.36 |
| 2024-03-31 | $9.9M | 244k | 40.68 |
| 2023-09-30 | $6.8M | 177k | 38.20 |
| 2023-06-30 | $1.6M | 46k | 36.07 |
More positions owned by Frontier Capital Management
View all positions for Frontier Capital Management